{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:10:11Z","timestamp":1782403811305,"version":"3.54.5"},"reference-count":34,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8763","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T07:50:43Z","timestamp":1521186643000},"source":"Crossref","is-referenced-by-count":5,"title":["Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition"],"prefix":"10.3892","author":[{"given":"Hangbin","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"key20200713225227_b1-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1097\/MPA.0b013e318291fbc5","article-title":"Modest improvement in overall survival for patients with metastatic pancreatic cancer: A trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008","volume":"42","author":"Worni","year":"2013","journal-title":"Pancreas"},{"key":"key20200713225227_b2-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200713225227_b3-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MOG.0000000000000096","article-title":"Recent advances in pancreatic surgery","volume":"30","author":"Bednar","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"key20200713225227_b4-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/0284186X.2017.1288922","article-title":"Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: A meta-analysis of randomized phase III trials","volume":"56","author":"Ottaiano","year":"2017","journal-title":"Acta Oncol"},{"key":"key20200713225227_b5-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejso.2007.07.204","article-title":"Neoadjuvant and adjuvant strategies for pancreatic cancer","volume":"34","author":"Ghaneh","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"key20200713225227_b6-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.critrevonc.2015.05.005","article-title":"Emerging concepts on drug resistance in bladder cancer: Implications for future strategies","volume":"96","author":"Massari","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200713225227_b7-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key20200713225227_b8-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fphar.2016.00421","article-title":"Pharmacodynamic modeling of cell cycle effects for gemcitabine and trabectedin combinations in pancreatic cancer cells","volume":"7","author":"Miao","year":"2016","journal-title":"Front Pharmacol"},{"key":"key20200713225227_b9-mmr-17-05-7274","first-page":"4","article-title":"Department of oncology, huangshan people's hospital, affiliated to wangnan medical college: The mechanism and countermeasures on the secondary resistance of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)","volume":"5","author":"Wu","year":"2015","journal-title":"Anti-Tumor Pharm"},{"key":"key20200713225227_b10-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"key20200713225227_b11-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-3189","article-title":"SPARC represses E-cadherin and induces mesenchymal transition during melanoma development","volume":"66","author":"Robert","year":"2006","journal-title":"Cancer Res"},{"key":"key20200713225227_b12-mmr-17-05-7274","first-page":"75","article-title":"Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20200713225227_b13-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1078-0432.CCR-12-3232","article-title":"Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT","volume":"19","author":"Neel","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20200713225227_b14-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.18632\/oncotarget.2714","article-title":"Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713225227_b15-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"key":"key20200713225227_b16-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/adhm.201400738","article-title":"Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response","volume":"4","author":"Kirui","year":"2015","journal-title":"Adv Healthc Mater"},{"key":"key20200713225227_b17-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3164\/jcbn.14-8","article-title":"The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines","volume":"55","author":"Kimura-Tsuchiya","year":"2014","journal-title":"J Clin Biochem Nutr"},{"key":"key20200713225227_b18-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"e61524","DOI":"10.1371\/journal.pone.0061524","article-title":"Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: Molecular events involved","volume":"8","author":"Meena","year":"2013","journal-title":"PLoS One"},{"key":"key20200713225227_b19-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr1841","article-title":"Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells","volume":"10","author":"Gu","year":"2008","journal-title":"Breast Cancer Res"},{"key":"key20200713225227_b20-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713225227_b21-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.cgt.7700387","article-title":"Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo","volume":"8","author":"Rigg","year":"2001","journal-title":"Cancer Gene Ther"},{"key":"key20200713225227_b22-mmr-17-05-7274","first-page":"285","volume-title":"DNA Cloning 4","author":"Gerald","year":"1996"},{"key":"key20200713225227_b23-mmr-17-05-7274","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J Virol"},{"key":"key20200713225227_b24-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3892\/ol.2017.5843","article-title":"High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1\/MMP2\/MMP9 axis expression","volume":"13","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200713225227_b25-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20200713225227_b26-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2011.09.066","article-title":"In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer","volume":"157","author":"Kim","year":"2012","journal-title":"J Control Release"},{"key":"key20200713225227_b27-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/bs.ctdb.2014.12.001","article-title":"Adhesion in mammary development: Novel roles for E-cadherin in individual and collective cell migration","volume":"112","author":"Shamir","year":"2015","journal-title":"Curr Top Dev Biol"},{"key":"key20200713225227_b28-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/bcr651","article-title":"E-cadherin expression in primary carcinomas of the breast and its distant metastases","volume":"5","author":"Kowalski","year":"2003","journal-title":"Breast Cancer Res"},{"key":"key20200713225227_b29-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1006\/cbir.2000.0647","article-title":"Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation","volume":"25","author":"Baruch","year":"2001","journal-title":"Cell Biol Int"},{"key":"key20200713225227_b30-mmr-17-05-7274","first-page":"4","article-title":"The regulation of MMP targeting to invadopodia during cancer metastasis","volume":"3","author":"Jacob","year":"2015","journal-title":"Fron Cell Dev Biol"},{"key":"key20200713225227_b31-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yexcr.2016.09.022","article-title":"Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2","volume":"349","author":"Chen","year":"2016","journal-title":"Exp Cell Res"},{"key":"key20200713225227_b32-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"9895721","DOI":"10.1155\/2016\/9895721","article-title":"Expressions of matrix metalloproteinases 2, 7 and 9 in carcinogenesis of pancreatic ductal adenocarcinoma","volume":"2016","author":"Jakubowska","year":"2016","journal-title":"Dis Markers"},{"key":"key20200713225227_b33-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1006760021997","article-title":"Heat shock-mediated transient increase in intracellular 3\u2032,5\u2032-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation","volume":"18","author":"Sawaji","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"key20200713225227_b34-mmr-17-05-7274","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:58:03Z","timestamp":1594681083000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8763","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]}}}